Untersuchungen zur Behandlung der zerebrospinalen Nematodiasis bei Ziegen

Translated title of the contribution: Therapeutical outcome of cerebrospinal nematodiasis in goats

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In 17 goats the therapeutical outcome of cerebrospinal nematodiasis, a parasitic infection in the central nervous system with the nematode Elaphostrongylus cervi, is described. The diagnosis was made on the basis of physical findings and cerebrospinal fluid eosinophilia. The therapy was based on the administration of a non-steroidal antiinflammatory drug (flunixin meglumine) and two anthelmintics (fenbendazol, ivermectin) for five days. The response to therapy was documented immediately and 30 days after therapy and by owners report up to 30 months. Eleven goats (64.7 %) showed an improvement of the neurological signs directly after therapy. Three had a complete recovery. Signs of a light and middle ataxie were still present in 6 and 2 goats, respectively. Six recumbent goats (35.3 %) had to be euthanasied because of a non-therapeutical response. This study has shown a clinical impression of successful use of flunixin meglumine, fenbendazole and ivermectin in goats with light to middle neurological signs. The goats could accommodate the remaining ataxia without showing a reduced production. Goats with high neurological deficits could not be successful treated based on the high degree of the neurological damage.

Original languageGerman
Pages (from-to)22-24
Number of pages3
JournalDeutsche Tierarztliche Wochenschrift
Volume106
Issue number1
StatePublished - 1999
Externally publishedYes

Fingerprint

Goats
goats
flunixin
Ivermectin
therapeutics
ivermectin
Central Nervous System Parasitic Infections
Elaphostrongylus
Fenbendazole
Cervus
Light
eosinophilia
fenbendazole
Anthelmintics
nonsteroidal anti-inflammatory agents
Eosinophilia
cerebrospinal fluid
Ataxia
Therapeutics
parasitoses

Keywords

  • Cerebrospinal nematodiasis
  • Elaphostrongylus cervi
  • Goats
  • Therapy454-455

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Untersuchungen zur Behandlung der zerebrospinalen Nematodiasis bei Ziegen. / Pusterla, Nicola.

In: Deutsche Tierarztliche Wochenschrift, Vol. 106, No. 1, 1999, p. 22-24.

Research output: Contribution to journalArticle

@article{ee9bd3c56a984da8ad08140ab5b3441a,
title = "Untersuchungen zur Behandlung der zerebrospinalen Nematodiasis bei Ziegen",
abstract = "In 17 goats the therapeutical outcome of cerebrospinal nematodiasis, a parasitic infection in the central nervous system with the nematode Elaphostrongylus cervi, is described. The diagnosis was made on the basis of physical findings and cerebrospinal fluid eosinophilia. The therapy was based on the administration of a non-steroidal antiinflammatory drug (flunixin meglumine) and two anthelmintics (fenbendazol, ivermectin) for five days. The response to therapy was documented immediately and 30 days after therapy and by owners report up to 30 months. Eleven goats (64.7 {\%}) showed an improvement of the neurological signs directly after therapy. Three had a complete recovery. Signs of a light and middle ataxie were still present in 6 and 2 goats, respectively. Six recumbent goats (35.3 {\%}) had to be euthanasied because of a non-therapeutical response. This study has shown a clinical impression of successful use of flunixin meglumine, fenbendazole and ivermectin in goats with light to middle neurological signs. The goats could accommodate the remaining ataxia without showing a reduced production. Goats with high neurological deficits could not be successful treated based on the high degree of the neurological damage.",
keywords = "Cerebrospinal nematodiasis, Elaphostrongylus cervi, Goats, Therapy454-455",
author = "Nicola Pusterla",
year = "1999",
language = "German",
volume = "106",
pages = "22--24",
journal = "Deutsche Tierarztliche Wochenschrift",
issn = "0341-6593",
publisher = "Verlag M. und H. Schaper GmbH",
number = "1",

}

TY - JOUR

T1 - Untersuchungen zur Behandlung der zerebrospinalen Nematodiasis bei Ziegen

AU - Pusterla, Nicola

PY - 1999

Y1 - 1999

N2 - In 17 goats the therapeutical outcome of cerebrospinal nematodiasis, a parasitic infection in the central nervous system with the nematode Elaphostrongylus cervi, is described. The diagnosis was made on the basis of physical findings and cerebrospinal fluid eosinophilia. The therapy was based on the administration of a non-steroidal antiinflammatory drug (flunixin meglumine) and two anthelmintics (fenbendazol, ivermectin) for five days. The response to therapy was documented immediately and 30 days after therapy and by owners report up to 30 months. Eleven goats (64.7 %) showed an improvement of the neurological signs directly after therapy. Three had a complete recovery. Signs of a light and middle ataxie were still present in 6 and 2 goats, respectively. Six recumbent goats (35.3 %) had to be euthanasied because of a non-therapeutical response. This study has shown a clinical impression of successful use of flunixin meglumine, fenbendazole and ivermectin in goats with light to middle neurological signs. The goats could accommodate the remaining ataxia without showing a reduced production. Goats with high neurological deficits could not be successful treated based on the high degree of the neurological damage.

AB - In 17 goats the therapeutical outcome of cerebrospinal nematodiasis, a parasitic infection in the central nervous system with the nematode Elaphostrongylus cervi, is described. The diagnosis was made on the basis of physical findings and cerebrospinal fluid eosinophilia. The therapy was based on the administration of a non-steroidal antiinflammatory drug (flunixin meglumine) and two anthelmintics (fenbendazol, ivermectin) for five days. The response to therapy was documented immediately and 30 days after therapy and by owners report up to 30 months. Eleven goats (64.7 %) showed an improvement of the neurological signs directly after therapy. Three had a complete recovery. Signs of a light and middle ataxie were still present in 6 and 2 goats, respectively. Six recumbent goats (35.3 %) had to be euthanasied because of a non-therapeutical response. This study has shown a clinical impression of successful use of flunixin meglumine, fenbendazole and ivermectin in goats with light to middle neurological signs. The goats could accommodate the remaining ataxia without showing a reduced production. Goats with high neurological deficits could not be successful treated based on the high degree of the neurological damage.

KW - Cerebrospinal nematodiasis

KW - Elaphostrongylus cervi

KW - Goats

KW - Therapy454-455

UR - http://www.scopus.com/inward/record.url?scp=0032612493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032612493&partnerID=8YFLogxK

M3 - Article

VL - 106

SP - 22

EP - 24

JO - Deutsche Tierarztliche Wochenschrift

JF - Deutsche Tierarztliche Wochenschrift

SN - 0341-6593

IS - 1

ER -